Editorial: glycyrrhizin against multi-resistant bacteria?
Steinstraesser
Lars
L
Schubert
Cornelius
C
Jacobsen
Frank
F
Al-Benna
Sammy
S
D000818:Animals; D002056:Burns / Q000150:complications; D004353:Drug Evaluation, Preclinical; D024901:Drug Resistance, Multiple, Bacterial; D019695:Glycyrrhizic Acid / Q000627:therapeutic use*; D006801:Humans; D007113:Immunity, Innate; D015603:Keratinocytes / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D014946:Wound Infection / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D023083:beta-Defensins / Q000096:biosynthesis
D023083:beta-Defensins; D019695:Glycyrrhizic Acid